STAT Plus: The biotech scorecard for the third quarter: 12 stock-moving events to watch
RYAN PIERSE/GETTY IMAGES
Amarin’s stock price could move most on an event that doesn’t happen and Sangamo Therapeutics is presenting updated clinical data on its gene therapy.
.png)
No hay comentarios:
Publicar un comentario